John C. Rutherford is Director at MEDASSETS INC (MDAS). They have made 10 open-market trades across 1 company since 2010, most recently 2014-02-27.
CIK 0001311158
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDAS | 6,485 | — |
Shares reported on the most recent Form 4, priced at the 2014-03-03 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDAS | SELL | 2013-11-25 | 2013-11-26 | $21.41 | $278K | N/A | N/A | N/A |
| MDAS | SELL | 2013-11-20 | 2013-11-22 | $20.68 | $248K | N/A | N/A | N/A |
| MDAS | SELL | 2013-08-08 | 2013-08-12 | $23.62 | $1.2M | N/A | N/A | N/A |
| MDAS | SELL | 2013-03-05 | 2013-03-07 | $19.20 | $480K | N/A | N/A | N/A |
| MDAS | SELL | 2011-11-10 | 2011-11-10 | $11.15 | $29.3M | N/A | N/A | N/A |
| MDAS | SELL | 2011-05-31 | 2011-06-01 | $14.45 | $8.5M | N/A | N/A | N/A |
| MDAS | SELL | 2010-11-29 | 2010-12-01 | $18.31 | $4.6M | N/A | N/A | N/A |
| MDAS | SELL | 2010-08-23 | 2010-08-24 | $20.42 | $11.8M | N/A | N/A | N/A |
| MDAS | SELL · 10b5-1 | 2010-07-07 | 2010-07-09 | $23.12 | $231K | N/A | N/A | N/A |
| MDAS | SELL · 10b5-1 | 2010-06-07 | 2010-06-09 | $23.11 | $231K | N/A | N/A | N/A |
| MDAS | SELL · 10b5-1 | 2010-05-12 | 2010-05-14 | $23.17 | $232K | N/A | N/A | N/A |
| MDAS | SELL · 10b5-1 | 2010-05-03 | 2010-05-05 | $22.85 | $13.7M | N/A | N/A | N/A |
| MDAS | SELL · 10b5-1 | 2010-04-26 | 2010-04-28 | $23.00 | $494K | N/A | N/A | N/A |
| MDAS | SELL | 2010-03-05 | 2010-03-09 | $20.70 | $6.2M | N/A | N/A | N/A |
| MDAS | SELL | 2010-03-02 | 2010-03-04 | $21.22 | $4.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.